SP
ABBV icon

Successful Portfolios’s AbbVie ABBV Stock Holding History

Successful Portfolios’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.22M Sell
4,909
-63
-1% -$13.6K 0.57% 40
2026
Q1 		$1.06M Sell
4,972
-1,957
-28% -$434K 0.59% 44
2025
Q4 		$1.52M Buy
6,929
+418
+6% +$95.2K 0.78% 35
2025
Q3 		$1.51M Sell
6,511
-369
-5% -$75.1K 0.88% 31
2025
Q2 		$1.28M Sell
6,880
-10
-0.1% -$1.86K 0.79% 31
2025
Q1 		$1.44M Hold
6,890
– – 0.98% 29
2024
Q4 		$1.22M Sell
6,890
-197
-3% -$36.2K 0.82% 30
2024
Q3 		$1.4M Sell
7,087
-400
-5% -$74.7K 0.95% 30
2024
Q2 		$1.28M Buy
7,487
+1
+0% +$166 0.9% 31
2024
Q1 		$1.36M Sell
7,486
-112
-1% -$19.3K 0.93% 29
2023
Q4 		$1.18M Buy
7,598
+385
+5% +$56.1K 0.88% 31
2023
Q3 		$1.08M Buy
7,213
+11
+0.2% +$1.61K 0.95% 27
2023
Q2 		$970K Sell
7,202
-499
-6% -$73.2K 0.84% 30
2023
Q1 		$1.23M Sell
7,701
-43
-0.6% -$6.57K 0.77% 34
2022
Q4 		$1.25M Buy
7,744
+1
+0% +$153 0.82% 28
2022
Q3 		$1.04M Hold
7,743
– – 0.75% 31
2022
Q2 		$1.19M Buy
7,743
+100
+1% +$15.3K 0.8% 29
2022
Q1 		$1.24M Sell
7,643
-87
-1% -$12.6K 0.71% 34
2021
Q4 		$1.05M Buy
7,730
+34
+0.4% +$4.02K 0.57% 43
2021
Q3 		$830K Buy
7,696
+1,021
+15% +$117K 0.5% 51
2021
Q2 		$752K Buy
6,675
+1
+0% +$113 0.46% 53
2021
Q1 		$722K Sell
6,674
-8
-0.1% -$856 0.48% 54
2020
Q4 		$716K Buy
6,682
+1
+0% +$96 0.51% 53
2020
Q3 		$585K Hold
6,681
– – 0.47% 60
2020
Q2 		$656K Buy
6,681
+288
+5% +$25.4K 0.58% 47
2020
Q1 		$487K Buy
6,393
+133
+2% +$11.3K 0.49% 61
2019
Q4 		$554K Sell
6,260
-208
-3% -$17.3K 0.49% 57
2019
Q3 		$490K Buy
6,468
+15
+0.2% +$1.03K 0.46% 63
2019
Q2 		$469K Buy
6,453
+25
+0.4% +$1.97K 0.5% 59
2019
Q1 		$518K Buy
6,428
+48
+0.8% +$3.93K 0.57% 51
2018
Q4 		$588K Hold
6,380
– – 0.75% 42
2018
Q3 		$603K Hold
6,380
– – 0.66% 43
2018
Q2 		$591K Sell
6,380
-121
-2% -$11.8K 0.69% 43
2018
Q1 		$615K Sell
6,501
-5
-0.1% -$549 0.75% 40
2017
Q4 		$629K Buy
+6,506
New +$613K 0.78% 38

Other funds holding ABBV

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Successful Portfolios's ABBV Position: Q2 2026 in Review

Successful Portfolios reduced its AbbVie (ABBV) stake by 1.3% in Q2 2026, selling an estimated $13.6K and leaving 4,909 shares worth $1.22M. The position accounts for 0.57% of the portfolio, ranked #40.

Successful Portfolios first reported a position in ABBV in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.52M in Q4 2025. 783 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Successful Portfolios held 4,909 shares of AbbVie worth $1.22M as of Q2 2026.
  • Successful Portfolios sold 63 AbbVie shares in Q2 2026, an estimated $13.6K.
  • AbbVie made up 0.57% of Successful Portfolios's portfolio in Q2 2026, its #40 holding.
  • Successful Portfolios first reported a position in AbbVie in Q4 2017 and has held it in 35 quarters since.
  • Successful Portfolios's AbbVie position peaked at $1.52M in Q4 2025.
  • 783 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Successful Portfolios's 13F filing for Q2 2026, filed 14 Jul 2026.